...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX
【24h】

The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX

机译:磺胺胺脱氨基硼烷对癌症相关碳酸酐酶IX的结构基础

获取原文
           

摘要

Human carbonic anhydrase IX (CA IX), a protein specifically expressed on the surface of solid tumour cells, represents a validated target both for anticancer therapy and diagnostics. We recently identified sulfonamide dicarbaboranes as promising inhibitors of CA IX with favourable activities both in?vitro and in?vivo. To explain their selectivity and potency, we performed detailed X-ray structural analysis of their interactions within the active sites of CA IX and CA II. Series of compounds bearing various aliphatic linkers between the dicarbaborane cluster and sulfonamide group were examined. Preferential binding towards the hydrophobic part of the active site cavity was observed. Selectivity towards CA IX lies in the shape complementarity of the dicarbaborane cluster with a specific CA IX hydrophobic patch containing V131 residue. The bulky side chain of F131 residue in CA II alters the shape of the catalytic cavity, disrupting favourable interactions of the spherical dicarbaborane cluster.
机译:人碳酸酐酶IX(Ca11),在实体肿瘤细胞表面上特异性表达的蛋白质,代表了抗癌治疗和诊断的验证靶标。我们最近将磺胺酰胺二氨基甲烷鉴定为具有良好活动的Ca IX的有前途抑制剂,在体外和βvivo中。为了解释他们的选择性和效力,我们对Ca IX和Ca II的活性位点内的相互作用进行了详细的X射线结构分析。检查轴承二碳硼烷基团和磺酰胺基之间各种脂族接头的系列化合物。观察到朝向活性位点腔的疏水部分的优先结合。对CA IX的选择性位于Dicarboborane群的形状互补性与含有V131残基的特异性Ca IX疏水贴剂。 C131中F131残基的庞大侧链改变了催化腔的形状,破坏了球形二碳甲烷簇的良好相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号